Patents by Inventor Rina K. Dukor

Rina K. Dukor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7378283
    Abstract: A method and apparatus to monitor the enantiomeric excess of chiral molecules participating in a chemical reaction. The method includes real time monitoring of the chemical reaction by obtaining a VCD spectra and an IR spectra of the chemical compounds in the reaction, and manipulating the spectra to obtain a % EE value. Using such real time information, the reaction parameters can be changed to shift the reaction to produce more of one chiral molecule than another.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: May 27, 2008
    Assignee: BioTools, Inc.
    Inventors: Laurence A. Nafie, Changning Guo, Rina K. Dukor
  • Patent number: 6841388
    Abstract: A method and system for diagnosing pathology, such as carcinoma, in a biological sample identifies presence of pathology based on the existence of an infrared markers in the extracellular material, rather than cells, in the biological sample. In the case of breast cancer diagnosis, an effective marker is a baseline slope of a 1280 cm?1 band in the infrared spectra of connective tissue, with normal biopsy samples exhibiting a positive slope and cancerous samples showing a relatively flat baseline. Infrared spectroscopy, both microscopic and macroscopic, may be used to identify a sample region containing extracellular material and to collect infrared absorbance data, from which the existence of the pathology marker is determined.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: January 11, 2005
    Assignees: Vysis, Inc., Procter & Gamble
    Inventors: Rina K. Dukor, Curtis A. Marcott
  • Publication number: 20020164810
    Abstract: A method and system for diagnosing pathology, such as carcinoma, in a biological sample identifies presence of pathology based on the existence of an infrared markers in the extracellular material, rather than cells, in the biological sample. In the case of breast cancer diagnosis, an effective marker is a baseline slope of a 1280 cm−1 band in the infrared spectra of connective tissue, with normal biopsy samples exhibiting a positive slope and cancerous samples showing a relatively flat baseline. Infrared spectroscopy, both microscopic and macroscopic, may be used to identify a sample region containing extracellular material and to collect infrared absorbance data, from which the existence of the pathology marker is determined.
    Type: Application
    Filed: November 28, 2001
    Publication date: November 7, 2002
    Applicant: Vysis
    Inventors: Rina K. Dukor, Curtis A. Marcott
  • Patent number: 6274871
    Abstract: A method and system performs Fourier transform infrared (FT-IR) imaging microspectroscopy on a biological sample fixed on a substrate with a supporting surface that generally reflects infrared light while generally transmitting visible light. Infrared light impinging on the biological sample is reflected by the supporting surface of the substrate. Infrared light from the sample is focused onto a focal-plane array detector with multiple pixels for detecting infrared images of the sample. The detected infrared images are processed to generate spectral images of the sample. The same biological sample is suitable for conventional pathological studies.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: August 14, 2001
    Assignees: VYSIS, Inc., The Procter and Gamble Company
    Inventors: Rina K. Dukor, Curtis A. Marcott
  • Patent number: 5945674
    Abstract: A method of detecting cellular types in a biological sample supported on an infrared absorptive substrate, such as a plain glass slide, analyzes infrared light reflected from the sample using an Attenuated Total Reflection (ATR) technique. An infrared beam is directed to the sample through an ATR microscope objective. The depth of penetration of the infrared beam in the sample is controlled to avoid infrared spectral response from the absorptive substrate. The attenuated total reflection from the sample is detected and analyzed to determine the cellular types or the presence of anomalies in the sample. The method allows infrared measurements on cell samples mounted on plain glass slides, as are normally used by pathologists and other medical investigators.
    Type: Grant
    Filed: July 30, 1997
    Date of Patent: August 31, 1999
    Assignee: Vysis, Inc.
    Inventor: Rina K. Dukor